Treatment with ACE inhibitors or ARBs and risk of severe/lethal COVID-19: a meta-analysis

This meta-analysis of adjusted observational data from 10 studies (n=9,890) found, compared with untreated subjects, those using either ACE inhibitors or ARBs showed a similar risk of severe or lethal COVID-19 (summary OR: 0.90;95% CI 0.65-1.26 and 0.92; 0.75-1.12,respectively)